See every side of every news story
Published loading...Updated

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer

Summary by MyChesCo
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Noah L. Rosenberg as Chief Medical Officer, a strategic move aimed at strengthening the company’s efforts in advancing its innovative dermatology treatments. Dr. Rosenberg brings more than 30 years of clinical and therapeutic drug development experience, including leadership roles at biotechnology companies that culminated in successful global app…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.